Respiratory Syncytial Virus (RSV) Study

Description

Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply.

Criteria & Qualifications:
• Must be 18 years or older and diagnosed with RSV within the last 5 days.
• Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization.
• Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition.

Compensation:

Contact us for more information

Contact Us

    Additional information

    Patient Population

    ,

    Study Status

    Active